263 related articles for article (PubMed ID: 21422819)
1. Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.
Singh R; Wallecha A
Hum Vaccin; 2011 May; 7(5):497-505. PubMed ID: 21422819
[TBL] [Abstract][Full Text] [Related]
2. Live-attenuated Listeria-based immunotherapy.
Rothman J; Paterson Y
Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
[TBL] [Abstract][Full Text] [Related]
3. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
Wood LM; Paterson Y
Front Cell Infect Microbiol; 2014; 4():51. PubMed ID: 24860789
[TBL] [Abstract][Full Text] [Related]
5. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
Brockstedt DG; Dubensky TW
Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
[TBL] [Abstract][Full Text] [Related]
6. Listeria monocytogenes and its products as agents for cancer immunotherapy.
Guirnalda P; Wood L; Paterson Y
Adv Immunol; 2012; 113():81-118. PubMed ID: 22244580
[TBL] [Abstract][Full Text] [Related]
7. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
Weiskirch LM; Paterson Y
Immunol Rev; 1997 Aug; 158():159-69. PubMed ID: 9314084
[TBL] [Abstract][Full Text] [Related]
8. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Singh R; Paterson Y
Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
[TBL] [Abstract][Full Text] [Related]
9. Clinical development of Listeria monocytogenes-based immunotherapies.
Le DT; Dubenksy TW; Brockstedt DG
Semin Oncol; 2012 Jun; 39(3):311-22. PubMed ID: 22595054
[TBL] [Abstract][Full Text] [Related]
10. Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.
Paterson Y; Guirnalda PD; Wood LM
Semin Immunol; 2010 Jun; 22(3):183-9. PubMed ID: 20299242
[TBL] [Abstract][Full Text] [Related]
11. Listeria-based vaccines for cancer treatment.
Paterson Y; Maciag PC
Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
[TBL] [Abstract][Full Text] [Related]
12. Recombinant
Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
[TBL] [Abstract][Full Text] [Related]
13. Listeria as a vaccine vector.
Bruhn KW; Craft N; Miller JF
Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Listeria monocytogenes cancer vaccines.
Paterson Y; Ikonomidis G
Curr Opin Immunol; 1996 Oct; 8(5):664-9. PubMed ID: 8902392
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
[TBL] [Abstract][Full Text] [Related]
16. Rekindling cancer vaccines.
Branca MA
Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
[No Abstract] [Full Text] [Related]
17. Prospects and progress of Listeria-based cancer vaccines.
Bolhassani A; Naderi N; Soleymani S
Expert Opin Biol Ther; 2017 Nov; 17(11):1389-1400. PubMed ID: 28823183
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
Wallecha A; Maciag PC; Rivera S; Paterson Y; Shahabi V
Clin Vaccine Immunol; 2009 Jan; 16(1):96-103. PubMed ID: 19020110
[TBL] [Abstract][Full Text] [Related]
19. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Listeria monocytogenes to target tumors.
Gravekamp C; Paterson Y
Cancer Biol Ther; 2010 Feb; 9(4):257-65. PubMed ID: 20139702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
